Mon, Apr 21, 2014, 6:13 AM EDT - U.S. Markets open in 3 hrs 17 mins

Recent

% | $
Quotes you view appear here for quick access.

Sangamo Biosciences Inc. Message Board

  • mrmem2002 mrmem2002 May 27, 2006 8:30 PM Flag

    negative article

    Here is a very negative article on SGMO
    doesnt sound encouraging for longs

    http://www.centientinvestor.com/content.php?cid=1059

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Right. Sangamo is a total scam. That's why so many pharma companies have partnered with them:

      ZFP TF-Engineered Cell Lines for the Manufacturing
      of Protein Pharmaceuticals
      ZFP TF-engineered cell lines can be developed to enhance production yields of protein pharmaceuticals and monoclonal antibodies.

      Our partners in this area have included:

      Medarex
      Pfizer
      Novartis
      Amgen
      Novo Nordisk

      Agricultural Biotechnology
      ZFP TFs can be used to regulate in plants, leading to potential applications in the development of new crops for optimized yield with enhanced nutritional properties.

      Our partners in this area have included:

      Dow AgroSciences
      Renessen

      Plus they have a partnership with Edwards Life Sciences.

      And:

      "Sangamo has signed collaborations with 16 corporate partners using the Company�s Universal GeneTools to accelerate the identification, functional analysis and validation of commerciallyrelevant gene targets in human cells, plants, or disease related pathogens. These partners include Pfizer, SmithKline Beecham, Millennium Pharmaceuticals, AstraZeneca, Schering AG, Bayer Corporation, Glaxo Wellcome, DuPont Pharmaceuticals, Japan Tobacco, Hoffmann-LaRoche, Immunex, Pharmacia & Upjohn, Genset SA, Warner-Lambert, Merck KGaA, and Johnson & Johnson."

      Sangamo sure has duped a room full of biochemists, molecular biologists, biogeneticists, microbiologists, and scientists from several otther fields. Amazing, huh?

    • That's not negative...actually pretty balanced. Points out the risk in investing in companies that only have a limited early stage pipeline...but also points out that there's promise in the technology. That it's being hyped by Stansberry and crew doesn't make Sangamo bad...I'll leave you to decide whether or not the stocks touts are bad.

    • well, that article is mostly a (pretty fair) slam against the hype from that recent stock newsletter...and it ends: "The bottom line is that ZFPs are not likely to be the "biggest medical advance in 25 years" as claimed by the website, at least not in the immediate future. But it is a promising technology, and Sangamo's progress bears monitoring."
      I'd hardly call that especially negative.

 
SGMO
13.99-0.27(-1.89%)Apr 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
AstraZeneca PLC
NYSEThu, Apr 17, 2014 4:00 PM EDT
KeyCorp.
NYSEThu, Apr 17, 2014 4:01 PM EDT